SE7714538L - 7-HALOGEN-3,20-DIOXO-1,4-PREGNADIENES AND -4-PREGNENES AND THEIR PREPARATION - Google Patents

7-HALOGEN-3,20-DIOXO-1,4-PREGNADIENES AND -4-PREGNENES AND THEIR PREPARATION

Info

Publication number
SE7714538L
SE7714538L SE7714538A SE7714538A SE7714538L SE 7714538 L SE7714538 L SE 7714538L SE 7714538 A SE7714538 A SE 7714538A SE 7714538 A SE7714538 A SE 7714538A SE 7714538 L SE7714538 L SE 7714538L
Authority
SE
Sweden
Prior art keywords
pregnadienes
pregnenes
dioxo
halogen
preparation
Prior art date
Application number
SE7714538A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE429865B (en
Inventor
M J Green
H-J Shue
E L Shapiro
M A Gentles
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of SE7714538L publication Critical patent/SE7714538L/en
Publication of SE429865B publication Critical patent/SE429865B/en

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Structural Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7714538A 1976-12-22 1977-12-20 PROCEDURE FOR PREPARING 3,20-DIOXO-7ALFA-HALOGEN-DELTA? 724-PREGNANCES AND -1,4-PREGNANCY SE429865B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Publications (2)

Publication Number Publication Date
SE7714538L true SE7714538L (en) 1978-06-23
SE429865B SE429865B (en) 1983-10-03

Family

ID=27115720

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7714538A SE429865B (en) 1976-12-22 1977-12-20 PROCEDURE FOR PREPARING 3,20-DIOXO-7ALFA-HALOGEN-DELTA? 724-PREGNANCES AND -1,4-PREGNANCY

Country Status (20)

Country Link
JP (1) JPS604198B2 (en)
AR (1) AR226806A1 (en)
AT (2) AT373269B (en)
BE (1) BE862089A (en)
DE (1) DE2756550C2 (en)
DK (1) DK153494C (en)
FI (1) FI63947C (en)
FR (1) FR2384793A1 (en)
GB (1) GB1575983A (en)
HK (1) HK584A (en)
HU (1) HU179784B (en)
IE (1) IE45950B1 (en)
IL (1) IL53636A (en)
MY (1) MY8500082A (en)
NL (1) NL180479C (en)
NO (1) NO151826C (en)
NZ (1) NZ186031A (en)
PT (1) PT67432B (en)
SE (1) SE429865B (en)
SG (1) SG58683G (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (en) 2017-10-02 2019-04-26 爱科来株式会社 The measurement of glycated proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
BE862089A (en) 1978-06-20
ATA909477A (en) 1983-05-15
IL53636A (en) 1983-05-15
HK584A (en) 1984-01-13
NO151826B (en) 1985-03-04
NL7714056A (en) 1978-06-26
DE2756550C2 (en) 1986-10-16
NO774359L (en) 1978-06-23
IE45950B1 (en) 1983-01-12
IE45950L (en) 1978-06-22
NL180479C (en) 1987-03-02
MY8500082A (en) 1985-12-31
GB1575983A (en) 1980-10-01
DK153494B (en) 1988-07-18
DE2756550A1 (en) 1978-07-06
FI63947C (en) 1983-09-12
JPS5379850A (en) 1978-07-14
DK153494C (en) 1989-02-20
PT67432A (en) 1978-01-01
SG58683G (en) 1985-01-11
FR2384793B1 (en) 1981-11-13
IL53636A0 (en) 1978-03-10
FI63947B (en) 1983-05-31
AT377566B (en) 1985-04-10
AT373269B (en) 1984-01-10
HU179784B (en) 1982-12-28
SE429865B (en) 1983-10-03
JPS604198B2 (en) 1985-02-01
FI773825A (en) 1978-06-23
PT67432B (en) 1979-05-23
FR2384793A1 (en) 1978-10-20
NO151826C (en) 1985-06-12
NZ186031A (en) 1984-07-31
NL180479B (en) 1986-10-01
DK569977A (en) 1978-09-28
ATA575980A (en) 1982-04-15
AR226806A1 (en) 1982-08-31

Similar Documents

Publication Publication Date Title
FI772778A (en) PORTABLA OCH FOERAENDERLIGA VAEGGSYSTEM
FI773870A (en) HANDSKFOERPACKNING OCH AEMNE FOER DENSAMMA
FI53560C (en) FOERFARANDE OCH ANORDNING FOER UPPRULLNING AV MATERIALBANOR
FI773558A (en) SKEPPSBOTTENFAERG OCH LIKNANDE
FI773031A (en) HAZLBARA AEGGPRODUKTER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI773519A (en) FLOTATIONSFOERFARANDE OCH UPPSAMLINGSKOMPOSITION
SE7608748L (en) ACYL-SACARINES AND ACYL-3-OXO-1,2-BENSISOTIAZOLINES
FI773784A (en) FRAMSTAELLNING AV VISSA IMMUNA NUCLEIN SYROR CELLDIALYSAT AND ANTIKROPPAR
FI773801A (en) HYDROXAMSYROR OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI773768A (en) LUGGTEXTILFOEREMAOL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
NL7702534A (en) BENZOYLPIPERIDYL ALKYLINDOLS AND METHODS FOR THEIR PREPARATION.
SE7606427L (en) AMPULL AND AMPULLBERARE
SE7706182L (en) SUBSTITUTED (3-LAGALKYLAMINO-2-R, 10-PROPOXY) PYRIDINES, THEIR PREPARATION AND USE
SE8003485L (en) PYRAZINOBENSODIAZEPINES, THEIR PREPARATION AND USE
FI773954A (en) STEROLINER OCH DERAS ANVAENDNING
FI772453A (en) DIHYDRO-OXO-NIKOTINSYROR OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
SE7705873L (en) BENZENESULPHONYCARBAMIDES AND PROCEDURES FOR THEIR PREPARATION
FI773822A (en) ANTITUMOERGLYKOSIDER OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV
DK510977A (en) HYGIENE-COSMETIC PREPARATION
SE7706724L (en) ALKINOLS AND PROCEDURES FOR THE PREPARATION THEREOF
SE7714538L (en) 7-HALOGEN-3,20-DIOXO-1,4-PREGNADIENES AND -4-PREGNENES AND THEIR PREPARATION
SE7706385L (en) VERBENON, MYRTENAL AND PINOKARVEOL
SE7713243L (en) SUBSTITUTED AMINOETANOLS, THEIR PREPARATION AND PHARMACEUTICAL USE
SE7714658L (en) 1,4-OXATINES AND PROCEDURES FOR THE PREPARATION THEREOF
FI772597A (en) BENSOESYROR OCH FOERFARANDE FOER DERAS FRAMSTAELLNING

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7714538

SPCG Supplementary protection certificate granted

Free format text: 7714538, EXPIRES: 20020917

NAL Patent in force

Ref document number: 7714538-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7714538-1

Format of ref document f/p: F